(VRSK) Verisk Analytics - Ratings and Ratios
Data Analytics, Risk Assessment, Claims Solutions, Underwriting Tools
VRSK EPS (Earnings per Share)
VRSK Revenue
| Risk via 10d forecast | |
|---|---|
| Volatility | 21.7% |
| Value at Risk 5%th | 33.4% |
| Relative Tail Risk | -6.19% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.14 |
| Alpha | -30.22 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.447 |
| Beta | 0.305 |
| Beta Downside | 0.295 |
| Drawdowns 3y | |
|---|---|
| Max DD | 35.06% |
| Mean DD | 5.25% |
| Median DD | 3.45% |
Description: VRSK Verisk Analytics October 14, 2025
Verisk Analytics, Inc. (NASDAQ:VRSK) provides data-driven analytics and technology platforms to insurers worldwide, covering underwriting, claims, fraud detection, catastrophe modeling, and specialty reinsurance workflows. Its product suite spans underwriting forms, rating rules, loss-cost services, life-insurance workflow automation, property-damage estimating tools, and international claims solutions for personal injury and motor franchises.
In FY 2023 the company generated roughly $2.9 billion in revenue, with the data-analytics segment delivering a 10 % year-over-year growth rate and an operating margin near 24 %. Key macro drivers include rising insurance loss costs tied to increasing frequency of extreme weather events-fueling demand for Verisk’s catastrophe-modeling services-and heightened regulatory scrutiny that pushes insurers toward more sophisticated compliance and fraud-detection tools. Additionally, the broader insurtech trend of digitizing underwriting workflows supports recurring revenue expansion for Verisk’s subscription-based offerings.
For a deeper dive into Verisk’s valuation metrics and scenario analyses, you might explore the ValueRay platform, which aggregates analyst forecasts and comparable peer data to help you assess the stock’s risk-adjusted upside.
VRSK Stock Overview
| Market Cap in USD | 30,327m |
| Sub-Industry | Research & Consulting Services |
| IPO / Inception | 2009-10-07 |
| Return 12m vs S&P 500 | -33.7% |
| Analyst Rating | 3.39 of 5 |
VRSK Dividends
| Dividend Yield | 0.80% |
| Yield on Cost 5y | 0.87% |
| Yield CAGR 5y | 9.63% |
| Payout Consistency | 100.0% |
| Payout Ratio | 25.1% |
VRSK Growth Ratios
| CAGR 3y | 9.30% |
| CAGR/Max DD Calmar Ratio | 0.27 |
| CAGR/Mean DD Pain Ratio | 1.77 |
| Current Volume | 2046.9k |
| Average Volume | 1292.8k |
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income (921.4m TTM) > 0 and > 6% of Revenue (6% = 181.8m TTM) |
| FCFTA 0.18 (>2.0%) and ΔFCFTA -2.02pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 14.40% (prev -8.59%; Δ 22.98pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.22 (>3.0%) and CFO 1.35b > Net Income 921.4m (YES >=105%, WARN >=100%) |
| Net Debt (2.78b) to EBITDA (1.66b) ratio: 1.68 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.19 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (139.9m) change vs 12m ago -1.80% (target <= -2.0% for YES) |
| Gross Margin 69.62% (prev 68.24%; Δ 1.39pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 56.08% (prev 61.87%; Δ -5.80pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 9.09 (EBITDA TTM 1.66b / Interest Expense TTM 148.5m) >= 6 (WARN >= 3) |
Altman Z'' 7.54
| (A) 0.07 = (Total Current Assets 2.70b - Total Current Liabilities 2.26b) / Total Assets 6.24b |
| (B) 1.23 = Retained Earnings (Balance) 7.68b / Total Assets 6.24b |
| warn (B) unusual magnitude: 1.23 — check mapping/units |
| (C) 0.25 = EBIT TTM 1.35b / Avg Total Assets 5.40b |
| (D) 1.33 = Book Value of Equity 7.78b / Total Liabilities 5.86b |
| Total Rating: 7.54 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 81.66
| 1. Piotroski 5.50pt = 0.50 |
| 2. FCF Yield 3.37% = 1.69 |
| 3. FCF Margin 36.83% = 7.50 |
| 4. Debt/Equity 12.98 = -2.50 |
| 5. Debt/Ebitda 1.68 = 0.62 |
| 6. ROIC - WACC (= 20.86)% = 12.50 |
| 7. RoE 404.3% = 2.50 |
| 8. Rev. Trend 61.65% = 4.62 |
| 9. EPS Trend 84.64% = 4.23 |
What is the price of VRSK shares?
Over the past week, the price has changed by +2.26%, over one month by -10.08%, over three months by -17.46% and over the past year by -24.49%.
Is Verisk Analytics a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of VRSK is around 189.78 USD . This means that VRSK is currently overvalued and has a potential downside of -12.82%.
Is VRSK a buy, sell or hold?
- Strong Buy: 3
- Buy: 3
- Hold: 10
- Sell: 2
- Strong Sell: 0
What are the forecasts/targets for the VRSK price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 258.4 | 18.7% |
| Analysts Target Price | 258.4 | 18.7% |
| ValueRay Target Price | 210.6 | -3.2% |
VRSK Fundamental Data Overview November 01, 2025
P/E Trailing = 33.4255
P/E Forward = 31.25
P/S = 10.0107
P/B = 110.9069
P/EG = 2.9688
Beta = 0.856
Revenue TTM = 3.03b USD
EBIT TTM = 1.35b USD
EBITDA TTM = 1.66b USD
Long Term Debt = 2.52b USD (from longTermDebt, last fiscal year)
Short Term Debt = 1.52b USD (from shortTermDebt, last quarter)
Debt = 4.89b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.78b USD (from netDebt column, last quarter)
Enterprise Value = 33.11b USD (30.33b + Debt 4.89b - CCE 2.11b)
Interest Coverage Ratio = 9.09 (Ebit TTM 1.35b / Interest Expense TTM 148.5m)
FCF Yield = 3.37% (FCF TTM 1.12b / Enterprise Value 33.11b)
FCF Margin = 36.83% (FCF TTM 1.12b / Revenue TTM 3.03b)
Net Margin = 30.41% (Net Income TTM 921.4m / Revenue TTM 3.03b)
Gross Margin = 69.62% ((Revenue TTM 3.03b - Cost of Revenue TTM 920.3m) / Revenue TTM)
Gross Margin QoQ = 70.13% (prev 70.30%)
Tobins Q-Ratio = 5.30 (Enterprise Value 33.11b / Total Assets 6.24b)
Interest Expense / Debt = 0.86% (Interest Expense 42.2m / Debt 4.89b)
Taxrate = 25.36% (76.6m / 302.1m)
NOPAT = 1.01b (EBIT 1.35b * (1 - 25.36%))
Current Ratio = 1.19 (Total Current Assets 2.70b / Total Current Liabilities 2.26b)
Debt / Equity = 12.98 (Debt 4.89b / totalStockholderEquity, last quarter 376.7m)
Debt / EBITDA = 1.68 (Net Debt 2.78b / EBITDA 1.66b)
Debt / FCF = 2.49 (Net Debt 2.78b / FCF TTM 1.12b)
Total Stockholder Equity = 227.9m (last 4 quarters mean from totalStockholderEquity)
RoA = 14.76% (Net Income 921.4m / Total Assets 6.24b)
RoE = 404.3% (Net Income TTM 921.4m / Total Stockholder Equity 227.9m)
RoCE = 49.13% (EBIT 1.35b / Capital Employed (Equity 227.9m + L.T.Debt 2.52b))
RoIC = 28.85% (NOPAT 1.01b / Invested Capital 3.49b)
WACC = 7.99% (E(30.33b)/V(35.22b) * Re(9.17%) + D(4.89b)/V(35.22b) * Rd(0.86%) * (1-Tc(0.25)))
Discount Rate = 9.17% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.89%
[DCF Debug] Terminal Value 75.88% ; FCFE base≈1.03b ; Y1≈1.14b ; Y5≈1.49b
Fair Price DCF = 151.2 (DCF Value 21.07b / Shares Outstanding 139.4m; 5y FCF grow 12.29% → 3.0% )
EPS Correlation: 84.64 | EPS CAGR: 6.95% | SUE: 0.39 | # QB: 0
Revenue Correlation: 61.65 | Revenue CAGR: 55.08% | SUE: -1.49 | # QB: 0
Additional Sources for VRSK Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle